[HTML][HTML] Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

A Reeve, E Simcox, D Turnbull - Ageing research reviews, 2014 - Elsevier
As the second most common age related neurodegenerative disease after Alzheimer's
disease, the health, social and economic impact resulting from Parkinson's disease will …

Cognition deficits in Parkinson's disease: mechanisms and treatment

C Fang, L Lv, S Mao, H Dong, B Liu - Parkinson's disease, 2020 - Wiley Online Library
Parkinson's disease (PD) is the second most common progressive neurodegenerative
disorder mainly in middle‐elderly population, which represents diverse nonmotor symptoms …

Living on the edge with too many mouths to feed: why dopamine neurons die

JP Bolam, EK Pissadaki - Movement Disorders, 2012 - Wiley Online Library
Although genes, protein aggregates, environmental toxins, and other factors associated with
Parkinson's disease (PD) are widely distributed in the nervous system and affect many …

Olfaction in Parkinson's disease and related disorders

RL Doty - Neurobiology of disease, 2012 - Elsevier
Olfactory dysfunction is an early 'pre-clinical'sign of Parkinson's disease (PD). The present
review is a comprehensive and up-to-date assessment of such dysfunction in PD and …

Noradrenergic modulation of cognition in health and disease

O Borodovitsyna, M Flamini, D Chandler - Neural plasticity, 2017 - Wiley Online Library
Norepinephrine released by the locus coeruleus modulates cellular processes and synaptic
transmission in the central nervous system through its actions at a number of pre‐and …

The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease

EK Pissadaki, JP Bolam - Frontiers in computational neuroscience, 2013 - frontiersin.org
Dopamine neurons of the substantia nigra pars compacta (SNc) are uniquely sensitive to
degeneration in Parkinson's disease (PD) and its models. Although a variety of molecular …

Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological …

ER Samuels, E Szabadi - Current neuropharmacology, 2008 - ingentaconnect.com
The locus coeruleus (LC), the major noradrenergic nucleus of the brain, gives rise to fibres
innervating most structures of the neuraxis. Recent advances in neuroscience have helped …

Parkinson's disease as a result of aging

M Rodriguez, C Rodriguez‐Sabate, I Morales… - Aging cell, 2015 - Wiley Online Library
It is generally considered that Parkinson's disease is induced by specific agents that
degenerate a clearly defined population of dopaminergic neurons. Data commented in this …

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease

LM Collins, A Toulouse, TJ Connor, YM Nolan - Neuropharmacology, 2012 - Elsevier
Idiopathic Parkinson's disease (PD) represents a complex interaction between the inherent
vulnerability of the nigrostriatal dopaminergic system, a possible genetic predisposition, and …

Noradrenergic mechanisms in neurodegenerative diseases: a theory

MR Marien, FC Colpaert, AC Rosenquist - Brain Research Reviews, 2004 - Elsevier
A deficiency in the noradrenergic system of the brain, originating largely from cells in the
locus coeruleus (LC), is theorized to play a critical role in the progression of a family of …